Abbott Laboratories (ABT)


Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a range of health care products. Abbott operates in five segments: Pharmaceutical Products, Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. In March 2012, STARLIMS Technologies, an Abbott company, acquired STARLIMS's French distributor Varilab; operations of two privately held Spanish businesses, operating as STARLIMS Iberica; a Dutch company, operating as STARLIMS Netherlands, with a branch office in Solna, Sweden; and the business of its Israeli distribution partner, STARLIMS Israel, Ltd. In addition, the Company established STARLIMS Germany GmbH, with offices in Witten, Germany. In January 2013, the Company completed the separation of its research-based pharmaceuticals business, which became AbbVie, a new independent biopharmaceutical company.

Filers who had this stock in their top 10: 28
13F Filers holding this stock: 1440
Aggregate shares on 09/30/2015: 1,026,590,053
Aggregate shares on 06/30/2015: 1,020,428,113
Percent change: 0.60%
Funds creating new positions: 83
Funds Adding to an existing position: 534
Funds closing out their position: 88
Funds reducing their position: 587
Heat Map Ranking for 09/30/2015 21
Heat Map Ranking for 06/30/2015 383
View recent insider trading info

13F Filers holding this stock

Quarter 1: Refresh

Changes in Holdings:

*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Schedule 13D and 13G filings submitted since 09/30/2015

Subscription required

Elevate your investments